文献速递头颈外科

全甲状腺切除与腺叶切除治疗散发性甲状腺髓样癌:系统综述与荟萃分析

Total Thyroidectomy vs Lobectomy for Sporadic Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2026-01-01

该系统综述与荟萃分析纳入9项回顾性研究共1371例散发性甲状腺髓样癌患者,比较全甲状腺切除与腺叶切除的肿瘤学结局。结果显示5年死亡率、总生存、结构复发、生化治愈及远处转移均无显著差异,但5年后全甲状腺切除与更高结构复发相关,且术后并发症更常见。

要点

  • 腺叶切除与全甲状腺切除在5年肿瘤学结局上无显著差异。
  • 5年后全甲状腺切除的结构复发率更高(OR 7.26)。
  • 全甲状腺切除的术后并发症更常见。

核心结论

  • 在选择的散发性甲状腺髓样癌患者中,腺叶切除的肿瘤学结局可能与全甲状腺切除相当。

主要发现

  • 5年死亡率无差异(RR 0.30,95%CI 0.07-1.35),5年以上死亡率无差异(RR 1.00,95%CI 0.40-2.47)。
  • 5年总生存相似(RR 1.02,95%CI 0.94-1.11)。
  • 5年结构复发无差异(OR 0.45,95%CI 0.14-1.49),但5年以上全甲状腺切除与更高结构复发相关(OR 7.26,95%CI 1.07-49.21)。
  • 5年及5年以上生化治愈无差异(OR 0.86,95%CI 0.47-1.56;OR 0.87,95%CI 0.26-2.89)。
  • 5年远处转移无差异(OR 1.64,95%CI 0.09-31.52),术后并发症在全甲状腺切除中更常见。

临床怎么用

  • 对于选择的散发性甲状腺髓样癌患者,可考虑腺叶切除作为全甲状腺切除的替代方案。

局限性

  • 基于回顾性研究,偏倚风险高4项、中等4项、低1项。
  • 敏感性分析未显示任何结局的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Total thyroidectomy is the established surgical standard for hereditary and sporadic medullary thyroid cancer (sMTC). However, for unilateral sporadic tumors, its benefit over lobectomy remains uncertain. OBJECTIVE: To compare oncologic outcomes between total thyroidectomy and lobectomy in patients with sMTC. DATA SOURCES AND STUDY SELECTION: MEDLINE, Embase, Scopus, and Cochrane Central Register of Controlled Trials were searched from inception to December 2025 to identify comparative studies on patients with sMTC who underwent total thyroidectomy or lobectomy. DATA EXTRACTION AND SYNTHESIS: Reviewers working independently and in duplicate screened titles, abstracts, and full-text articles for eligibility using standardized instructions. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines were used for reporting. MAIN OUTCOMES AND MEASURES: Primary outcomes were mortality, overall survival, structural recurrence, biochemical cure, and distant metastasis development. The secondary outcome was postoperative complications. Effect measures were calculated as odds ratios (ORs) or relative risks (RRs) with 95% CIs using a random-effects model. The risk of bias was assessed using the Newcastle-Ottawa Scale. RESULTS: Nine retrospective studies met inclusion criteria and comprised 1371 patients (295 of 397 patients [74.3%] with documented sex were female, and median age ranged from 45.0 to 58.2 years). A total of 531 patients (38.7%) underwent lobectomy and 840 (61.3%) underwent total thyroidectomy. Of 341 tumors, 280 (82.1%) lacked extrathyroidal extension, 284 of 401 tumors (70.8%) measured smaller than 2 cm (70.8%), and 197 of 343 tumors (57.4%) were node negative; central neck dissection was performed in 445 of 492 patients (90.4%). Multifocal disease was uncommon and reported in 30 of 330 patients (9.1%). Mortality did not differ at 5 years (RR, 0.30; 95% CI, 0.07-1.35) or beyond (RR, 1.00; 95% CI, 0.40-2.47). Overall survival at 5 years was similar (RR, 1.02; 95% CI, 0.94-1.11). Total thyroidectomy was not associated with lower structural recurrence rates at 5 years (OR, 0.45; 95% CI, 0.14-1.49), but it was associated beyond 5 years (OR, 7.26; 95% CI, 1.07-49.21). No differences were observed for biochemical cure at 5 years (OR, 0.86; 95% CI, 0.47-1.56) or beyond 5 years (OR, 0.87; 95% CI, 0.26-2.89). Distant metastasis development did not differ at 5 years (OR, 1.64; 95% CI, 0.09-31.52). Sensitivity analyses revealed no differences across any outcomes. Postoperative complications were more common in total thyroidectomy. Risk of bias was high in 4 studies, moderate in 4, and low in 1. CONCLUSIONS AND RELEVANCE: Findings in this systematic review and meta-analysis, based on data from retrospective studies, suggest that thyroid lobectomy may be associated with oncologic outcomes comparable to total thyroidectomy in selected patients with sMTC.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Lincango EP, Vilatuna-Andrango L, Arce-Camposano A, et al. Total Thyroidectomy vs Lobectomy for Sporadic Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 41746657. doi:10.1001/jamaoto.2025.5599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。